Pharmaceutical Industry News
Analysis of regulation, quality, innovation, market and trends in Europe and Latin America.
New historical and regulatory milestone for cannabis in Brazil: ANVISA publishes new RDCs (Collegiate Board Resolutions) and advances the regulation of medicinal cannabis.
The Collegiate Board Resolutions (RDC) No. 1,011/2026, No. 1,012/2026, No. 1,013/2026, No. 1,014/2026, and No. 1,015/2026 were published in the Official Gazette...
Exports of Medicines Temporarily Suspended to Ensure National Supply
The National Medicines and Health Products Authority (Infarmed) has updated the list of medicines whose export is temporarily banned. The new version...
Anvisa promotes direct consultation on new regulatory framework for medical devices
The National Health Surveillance Agency (Anvisa) has announced the opening of a targeted consultation on the new proposal for a federal regulatory...
Public Consultation on Medicinal Cannabis Products: Anvisa’s Main Proposals
As of April 4, 2025, Anvisa launched a public consultation (CP 1.316/2025) to update the rules on cannabis products for medicinal use...
Anvisa publishes new resolution on Good Manufacturing Practices for Medicines
Anvisa (National Health Surveillance Agency) published Collegiate Board Resolution (RDC) No. 972/2025 in the Federal Official Gazette last Wednesday, April 23, 2025....
Public Consultation on the Revision of RDC 327/2019: Main Changes and Criticisms
On March 26, 2025, the public consultation on the revision of RDC 327/2019, which regulates the health authorization, manufacture, import, marketing, prescription...
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.